Previous studies have shown that OXCT1 was a key factor in promoting tumor progression and drug resistance in liver, lung, and pancreatic cancers, and was closely related to energy metabolism, proliferation, and survival of cancer cells. The gene discussed is OXCT1; the disease is pancreatic neoplasm.